Home
HEALTH CARE
Allergy and hay fever
Antineoplastic and immunomodulating agents
Circulatory system
Colds and flu
Dermatology
Digestive system
Eyes
For diabetics
Homeopathy
Musculoskeletal system
Non-sex hormones
Nutrikosmetics
Pain
Preparations for the treatment of infections
Sex and contraception
The immune system
The nervous system
Urogenital tract
Vitamins and minerals
HEALTHY LIFESTYLE
For athletes
Healthy food
Slimming
HYGIENE
Disinfection
Ear hygiene
Hot and cold compresses
Intimate hygiene
Laundry products
Oral hygiene
Slices and sticks
Urinary incontinence
COSMETICS
Cosmetic articles
For eyelashes and eyebrows
For face
For hair
For hands and nails
For the body
Soap
Sunbathing
To the feet
To the mouth
FOR HIM
Cosmetics for men
Health
PREGNANCY AND MOTHERHOOD
Accessories
Cosmetics for pregnant women
Health in pregnancy
Supporting fertility
CHILD
Baby nutrition
Child health
Cosmetics for children
Hygiene items for children
Oral hygiene (for children)
Scrolling
HEALTH CARE
Lozap 100 Plus 100mg/25mg 90 tablets — Made in Czech Republic — Free Delivery
Lozap 100 Plus 100mg/25mg 90 tablets — Made in Czech Republic — Free Delivery
Brand:
Zentiva
Product Code:
Lozap 100 Plus
Availability:
2 - 3 Days
$29.96
Add to Cart
Description
Product d
escription
Lozap 100 Plus tablets are indicated for essential arterial hypertension in patients in whom monotherapy with losartan or hydrochlorothiazide does not adequately control blood pressure.
Compound
Active ingredients: losartan potassium, hydrochlorothiazide;
1 tablet contains losartan potassium 100 mg, hydrochlorothiazide 25 mg;
Excipients: lactose, microcrystalline cellulose, corn starch, magnesium stearate, Opadry 20A52184 yellow (hydroxypropyl cellulose, hypromellose, titanium dioxide (E 171), quinoline yellow aluminum Lake (E 104), iron oxide yellow (E 172), iron oxide black ( E 172).
Contraindications
Hypersensitivity to losartan or to the components of the preparation.
Hypersensitivity to sulfonamide derivatives (such as hydrochlorothiazide).
Treatment-resistant hypokalemia or hypercalcemia.
Anuria.
Severe liver dysfunction, cholestasis and disorders associated with obstruction of the biliary tract.
Refractory hyponatremia.
Symptomatic hyperuricemia / gout.
Severe renal impairment (creatinine clearance <30 ml / min).
Pregnancy or planning a pregnancy.
Simultaneous use of the preparation with preparations that contain aliskiren, in the presence of diabetes mellitus or impaired renal function (GFR <60 ml / min / 1.73 m2).
Childhood.
Mode of application
The preparation can be used regardless of food intake. The tablet should be swallowed with water.
The preparation can be administered in conjunction with other antihypertensive preparations.
The combination of losartan and hydrochlorothiazide is not intended for use as initial therapy. It is indicated only in patients in whom blood pressure cannot be adequately controlled with losartan potassium monotherapy or hydrochlorothiazide monotherapy. It is recommended to perform dose titration for each component separately (for losartan and hydrochlorothiazide). In clinically acceptable cases, the feasibility of a direct transition from monotherapy to a fixed combination may be considered for patients in whom it is not possible to adequately control the level of blood pressure.
Application features
Pregnant
Contraindicated.
Children
Contraindicated.
Drivers
Carefully.
Overdose
There is no data on the specific treatment of preparation overdose. In case of overdose, treatment should be discontinued, and the patient should be monitored. If the preparation is recently taken, you need to induce vomiting and take measures aimed at eliminating dehydration, electrolyte disturbances, hepatic coma and arterial hypotension. Treatment is symptomatic and supportive.
Side effects
From the nervous system. Frequency unknown: dysgeusia.
On the part of the cardiovascular system. Frequency unknown: dose-dependent orthostatic effects.
Hepatobiliary system. Rarely hepatitis.
On the part of the skin and the immune system. Frequency unknown: cutaneous lupus erythematosus.
Research results. Rarely: hyperkalemia, increased levels of alanine aminotransferase (ALT).
Interaction
The simultaneous use of the preparation with preparations containing aliskiren is contraindicated in the presence of diabetes mellitus or renal dysfunction (GFR <60 ml / min / 1.73 m2).
Storage conditions
Does not require special storage conditions.
Keep out of the reach of children.
Shelf life is 3 years.
0 reviews
There are no reviews for this product.